Journal article
The National COVID-19 Clinical Evidence Taskforce: pregnancy and perinatal guidelines
CSE Homer, V Roach, L Cusack, ML Giles, C Whitehead, W Burton, T Downton, G Gleeson, A Gordon, K Hose, J Hunt, J Kitschke, N McDonnell, P Middleton, JJN Oats, AW Shand, K Wilton, J Vogel, J Elliott, S McGloughlin Show all
Medical Journal of Australia | Published : 2022
DOI: 10.5694/mja2.51729
Abstract
Introduction: Pregnant women are at higher risk of severe illness from coronavirus disease 2019 (COVID-19) than non-pregnant women of a similar age. Early in the COVID-19 pandemic, it was clear that evidenced-based guidance was needed, and that it would need to be updated rapidly. The National COVID-19 Clinical Evidence Taskforce provided a resource to guide care for people with COVID-19, including during pregnancy. Care for pregnant and breastfeeding women and their babies was included as a priority when the Taskforce was set up, with a Pregnancy and Perinatal Care Panel convened to guide clinical practice. Main recommendations: As of May 2022, the Taskforce has made seven specific recommen..
View full abstractGrants
Funding Acknowledgements
The National COVID-19 Clinical Evidence Taskforce staff are: Tari Turner, Leila Cusack, Joshua Vogel, Julian Elliot, Steve McGloughlin, Steve McDonald, Heath White and Saskia Cheyne. The National COVID-19 Clinical Evidence Taskforce is funded by the Australian Government Department of Health and Aged Care, the Victorian Government Department of Health, the Ian Potter Foundation, the Walter Cottman Endowment Fund (managed by Equity Trustees), and the Lord Mayor's Charitable Foundation. The funders played no role in developing the pregnancy and perinatal guidelines, writing this article, or deciding to submit this article for publication. The Taskforce panel members are all volunteers and provide their valuable time at no cost, for which we are very appreciative.